The Infrastructure Play Hiding in Plain Sight Across Cardiac Care

• VentriPoint Diagnostics (TSXV: VPT) announced a partnership with the Montecristo Group to deploy its VMS+™ AI cardiac imaging platform across Costa Rica's public and private hospital networks.
• The collaboration focuses on remote screening for congenital and structural heart disease via the Metropolitano Research Institute.
• This follows recent expansions in Canada (First Light Health) and Northern California (LG Consulting Solutions).
• Other industry news includes GE HealthCare/Medtronic surgical integration, Intuitive Surgical FDA clearance for da Vinci 5 cardiac procedures, and Johnson & Johnson clinical trial results showing neutral primary endpoints for STEMI DTU.
• The release highlights the company's "hub-and-spoke" remote diagnostics model as a scalable growth catalyst.

• Geographic Expansion: Entry into Costa Rica represents a new international market beyond North America and Europe, validating the global scalability of the VMS+ platform.
• Incremental Nature: The partnership structure mirrors previous announcements (First Light Health, LG Consulting), suggesting this is part of an established rollout strategy rather than a sudden breakthrough contract.
• Market Reaction Context: Historical price data shows stock stagnation ($0.10-$0.13) despite similar partnership news in March 2026, indicating the market views these announcements as incremental rather than transformative.
• Revenue Visibility: The release describes a "deployment" and "integration" but does not disclose specific revenue figures or contract values, maintaining ambiguity on immediate financial impact.

• Company: VentriPoint Diagnostics Ltd., listed on TSX Venture Exchange (VPT).
• Flagship Project: VMS+™ AI-powered cardiac imaging platform.
• Technology: Converts standard 2D ultrasound scans into detailed 3D heart models comparable to cardiac MRI without requiring MRI infrastructure.
• Regulatory Status: FDA cleared (510(k) in Feb 2025), Health Canada licensed, EU MDR certified.
• Business Model: Transitioning from equipment sales to a Device-as-a-Service (DaaS) subscription model to generate recurring revenue and shorten sales cycles.